We asked Brian Wolpin, the presenter for yesterday’s plenary on the daraxonrasib pancreatic cancer study, about the sustained ...
With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway ...
Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but ...
DETROIT — Two scientists at a U.S. government lab were charged with smuggling vials of deactivated mpox virus into the country from Africa and lying about it during interviews with investigators at a ...
Growing legislative scrutiny across multiple states targets the corporate structure underlying most direct-to-consumer ...
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
The FDA has missed a self-imposed deadline to ban the use of electrical shock devices in people with intellectual ...
A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using ...
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...
At the world's largest cancer research meeting, new data were plentiful. But this year, there was also a focus on grief.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results